CD4 T cells and their role in antitumor immune responses

被引:439
作者
Toes, REM
Ossendorp, F
Offringa, R
Melief, CJM
机构
[1] Leiden Univ, Med Ctr, Dept Immunohematol, NL-2333 AZ Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Blood Bank, NL-2333 AZ Leiden, Netherlands
[3] Inst Zellbiol, Immunol Abt, D-72076 Tubingen, Germany
关键词
D O I
10.1084/jem.189.5.753
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:753 / 756
页数:4
相关论文
共 37 条
[1]   CD4+ T cell tolerance to parenchymal self-antigens requires presentation by bone marrow-derived antigen-presenting cells [J].
Adler, AJ ;
Marsh, DW ;
Yochum, GS ;
Guzzo, JL ;
Nigam, A ;
Nelson, WG ;
Pardoll, DM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (10) :1555-1564
[2]  
ALLAN W, 1990, J IMMUNOL, V144, P3980
[3]  
BEAR HD, 1988, CANCER RES, V48, P1422
[4]   Help for cytotoxic-T-cell responses is mediated by CD40 signalling [J].
Bennett, SRM ;
Carbone, FR ;
Karamalis, F ;
Flavell, RA ;
Miller, JFAP ;
Heath, WR .
NATURE, 1998, 393 (6684) :478-480
[5]   Induction of a CD8(+) cytotoxic T lymphocyte response by cross-priming requires cognate CD4(+) T cell help [J].
Bennett, SRM ;
Carbone, FR ;
Karamalis, F ;
Miller, JFAP ;
Heath, WR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (01) :65-70
[6]   CROSS-PRIMING FOR A SECONDARY CYTOTOXIC RESPONSE TO MINOR H-ANTIGENS WITH H-2 CONGENIC CELLS WHICH DO NOT CROSS-REACT IN CYTOTOXIC ASSAY [J].
BEVAN, MJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1976, 143 (05) :1283-1288
[7]   LINKED RECOGNITION OF HELPER AND CYTO-TOXIC ANTIGENIC DETERMINANTS FOR THE GENERATION OF CYTO-TOXIC LYMPHOCYTES-T [J].
CASSELL, D ;
FORMAN, J .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1988, 532 :51-60
[8]   Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation [J].
Cella, M ;
Scheidegger, D ;
PalmerLehmann, K ;
Lane, P ;
Lanzavecchia, A ;
Alber, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (02) :747-752
[9]   Identification of MAGE-3 epitopes presented by HLA-DR molecules to CD4+ T lymphocytes [J].
Chaux, P ;
Vantomme, V ;
Stroobant, V ;
Thielemans, K ;
Corthals, J ;
Luiten, R ;
Eggermont, AMM ;
Boon, T ;
van der Bruggen, P .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (05) :767-777
[10]  
FOSTER I, 1996, EUR J IMMUNOL, V26, P3194